Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending December 2026 (Japanese GAAP, Consolidated)

Overview of Results

In this interim period, amid heightened global economic uncertainty, all four segments—Dental, DCI, Surgical, and Machinery—achieved double-digit revenue growth. Net sales reached 47,234 million yen, EBITDA 12,769 million yen, operating income 10,012 million yen, ordinary income 11,577 million yen, and net income attributable to owners of the parent of 8,144 million yen, marking a substantial increase. Segment-wise, all components performed steadily. The company added two new subsidiaries (Acra Cut, Inc. and Intech, Inc.), expanding the consolidated scope. A stock split was approved, and the company published revised full-year guidance.

Outlook and Capital Policy

Full-year performance for the fiscal year ending December 2026 has been revised. Per-share metrics have been adjusted based on the stock split, with per-share net income for the period disclosed considering the split. If the split is not taken into account, the full-year outlook remains aligned with the previous guidance. The addition of new subsidiaries and this broader portfolio are expected to sustain growth. In terms of capital management, there has been no disclosure of treasury stock movements, but attention should be paid to related materials on the split and dividend policy.